Shares of Syneos Health Inc (NASDAQ:SYNH) were up 0% during trading on Monday . The stock traded as high as $36.40 and last traded at $34.70. Approximately 3,585,500 shares traded hands during trading, an increase of 253% from the average daily volume of 1,016,607 shares. The stock had previously closed at $34.70.
Several analysts recently commented on SYNH shares. KeyCorp reiterated a “market perform” rating and set a $46.00 price target (down from $68.00) on shares of Syneos Health in a research report on Monday, November 13th. Robert W. Baird cut Syneos Health to an “outperform” rating and dropped their price target for the stock from $67.00 to $46.00 in a research report on Friday, November 10th. Mizuho set a $41.00 price target on Syneos Health and gave the stock a “neutral” rating in a research report on Friday, December 1st. Zacks Investment Research cut Syneos Health from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 16th. Finally, Jefferies Group reiterated a “buy” rating and set a $55.00 price target on shares of Syneos Health in a research report on Friday, November 10th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $48.89.
The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.99. The stock has a market cap of $3,620.00, a PE ratio of -60.88, a P/E/G ratio of 1.02 and a beta of 0.80.
A number of large investors have recently modified their holdings of SYNH. Globeflex Capital L P purchased a new stake in Syneos Health in the 4th quarter valued at $210,000. Municipal Employees Retirement System of Michigan purchased a new stake in Syneos Health in the 4th quarter valued at $741,000. Finally, Geode Capital Management LLC purchased a new stake in Syneos Health in the 4th quarter valued at $23,570,000. Institutional investors own 96.41% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3224069/syneos-health-synh-trading-up-0.html.
About Syneos Health
Syneos Health, Inc, formerly INC Research Holdings, Inc, is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for Syneos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneos Health and related companies with MarketBeat.com's FREE daily email newsletter.